TABLE 1.
Site |
No. (%) of samples tested |
No. (%) of PV-positive samples within each genusa |
No. of unique PV types detected within each genus |
Cumulative no. (%) of PV infection detected within each genus |
|||||||||
Total | PV-positive | α | β | γ | Total | α | β | γ | Total | α | β | γ | |
Genital | 117 | 65 (55.6) | 56 (86.2) | 1 (1.5) | 21 (32.3) | 52 | 32 | 1 | 19 | 198 | 159 (80.3) | 1 (0.5) | 38 (19.2) |
Perianal | 117 | 35 (29.9) | 18 (51.4) | 1 (2.9) | 18 (51.4) | 36 | 17 | 1 | 18 | 72 | 43 (59.7) | 1 (1.4) | 28 (38.9) |
Oral | 117 | 42 (35.9) | 3 (7.1) | 4 (9.5) | 38 (90.5) | 28 | 2 | 1 | 25 | 72 | 3 (4.2) | 4 (5.6) | 65 (90.3) |
Total | 351 | 142 (40.5) | 77 (54.2) | 6 (4.2) | 77 (54.2) | 72 | 32 | 1 | 39 | 342 | 205 (59.9) | 6 (1.8) | 131 (38.3) |
aSamples with PV infection from >1 genus were counted for each genus.